VCs Piling Into Oncology, Chasing Pharma Deals
This article was originally published in Start Up
Executive Summary
Oncology continues to dominate the therapeutic focus of VC investors. Here we take a look at the 181 private biotechnology companies funded so far this year to determine which therapeutic areas are hot.